دورية أكاديمية
[Use of Statins, Anticoagulants, Antiaggregants and Antiarrhythmic Drugs in Patients With COVID-19. The Agreed Experts' Position of Russian Society of Cardiology, Eurasian Association of Therapists, National Society on Atherothrombosis, Societies of Experts in Urgent Cardiology, Eurasian Arrhythmology Association].
| العنوان: | [Use of Statins, Anticoagulants, Antiaggregants and Antiarrhythmic Drugs in Patients With COVID-19. The Agreed Experts' Position of Russian Society of Cardiology, Eurasian Association of Therapists, National Society on Atherothrombosis, Societies of Experts in Urgent Cardiology, Eurasian Arrhythmology Association]. |
|---|---|
| المؤلفون: | Shlyakhto YV; Almazov National Medical Research Centre of Ministry of Healthcare of Russia, Saint- Petersburg., Arutyunov GP; Pirogov Russian National Research Medical University, Moscow., Belenkov YN; First Moscow state medical University I. M. Sechenov, Moscow., Tarlovskaya EI; Volga Research Medical University, Nizhny Novgorod., Konradi AO; National research medical center V. A. Almazov of Ministry of Healthcare of Russia, Saint-Petersburg., Panchenko EP; National Medical Research Center of Cardiology, Moscow., Yavelov IS; National Medical Research Center for Therapy and Preventive Medicine, Moscow., Tereshchenko SN; National Medical Research Center of Cardiology, Moscow., Ardashev AV; Lomonosov Moscow State University, Moscow., Arutyunov AG; Pirogov Russian National Research Medical University, Moscow., Grigorieva NY; Volga Research Medical University, Nizhny Novgorod., Dzhunusbekova GA; Kazakh Medical University of Contnuing Education, Alma-Atyu., Drapkina OM; National Center for Therapy and Preventive Medicine, Moscow., Koziolova NA; State funded educational institution of the highest education 'E.A. Wagner Perm State Medical University' Public Health Ministry of Russian Federation, Perm., Komarov AL; Department of clinical problems of atherothrombosis 'NMIC cardiology' of the Ministry of health of the Russian Federation, Moscow., Kropacheva ES; National Medical Research Centre of Cardiology, Moscow., Malchikova SV; Kirov State Medical University Kirov State Medical University, Kirov., Mitkovskaya NP; Cardiology and internal diseases of BSMU, Republic of Belarus, Minsk., Orlova YA; Lomonosov Moscow State University, Moscow., Petrova MM; Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenetsky, Krasnoyarsk., Rebrov AP; Saratov State Medical University named after V.I. Razumovsky, Saratov., Sisakian H; Yerevan State Medical University, Yerevan., Skibitsky VV; Cuban State Medical University, Krasnodar., Sugraliyev AB; Asfendiyarov Kazakh National Medical University, Alma-Atyu., Fomin IV; Volga Research Medical University, Nizhny Novgorod., Chesnikova AI; Rostov State Medical University, Rostov-on-Don., Shaposhnik II; South Ural state medical University, Chelyabinsk., Zhelyakov EG; Lomonosov Moscow State University, Moscow., Kanorskii SG; Kuban State Medical University of the Ministry of Healthcare of the Russian Federation, Krasnodar., Kolotsey LV; Grodno State Medical University, Grodno., Snezhitskiy VA; Grodno State Medical University, Grodno. |
| المصدر: | Kardiologiia [Kardiologiia] 2020 May 25; Vol. 60 (6), pp. 1180. Date of Electronic Publication: 2020 May 25. |
| نوع المنشور: | Journal Article; Practice Guideline |
| اللغة: | Russian |
| بيانات الدورية: | Publisher: |
| أسماء مطبوعة: | Publication: <2017->: Moskva : OOO "Obshchestvo spet︠s︡ialistov po serdechnoĭ nedostatochnosti" Original Publication: Moskva. |
| مواضيع طبية MeSH: | Anticoagulants*/therapeutic use , Cardiology* , Coronavirus Infections*/drug therapy , Coronavirus Infections*/epidemiology , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Pandemics* , Pneumonia, Viral*/drug therapy , Pneumonia, Viral*/epidemiology, Anti-Arrhythmia Agents/therapeutic use ; Betacoronavirus ; COVID-19 ; Humans ; Russia ; SARS-CoV-2 ; Societies, Medical ; COVID-19 Drug Treatment |
| مستخلص: | This article discusses relevant aspects in the treatment of patients with COVID-19. Up-to-date information about principles for administration of statins, antithrombotics, and antiarrhythmics is presented. The authors addressed in detail specific features of reversing heart rhythm disorders in patients with coronavirus infection and the interaction of antiarrhythmic and antiviral drugs. Recommendations are provided for outpatient and inpatient antithrombotic therapy for patients with COVID-19. Issues of antithrombotic and antiviral drug interaction are discussed. |
| المشرفين على المادة: | 0 (Anti-Arrhythmia Agents) 0 (Anticoagulants) 0 (Hydroxymethylglutaryl-CoA Reductase Inhibitors) |
| تواريخ الأحداث: | Date Created: 20200729 Date Completed: 20200729 Latest Revision: 20221207 |
| رمز التحديث: | 20231215 |
| DOI: | 10.18087/cardio.2020.6.n1180 |
| PMID: | 32720611 |
| قاعدة البيانات: | MEDLINE |
كن أول من يترك تعليقا!